These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32129122)

  • 1. Bladder-sparing treatment options in localized muscle-invasive bladder cancer.
    Nason GJ; Ajib K; Tan GH; Kulkarni GS
    Expert Rev Anticancer Ther; 2020 Mar; 20(3):179-188. PubMed ID: 32129122
    [No Abstract]   [Full Text] [Related]  

  • 2. Trimodal therapy for muscle-invasive bladder cancer.
    Mathes J; Rausch S; Todenhöfer T; Stenzl A
    Expert Rev Anticancer Ther; 2018 Dec; 18(12):1219-1229. PubMed ID: 30324833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trimodal therapy in muscle invasive bladder cancer management.
    Polo-Alonso E; Kuk C; Guruli G; Paul AK; Thalmann G; Kamat A; Solsona E; Thalmann G; Urdaneta AI; Zlotta AR; Mir MC
    Minerva Urol Nefrol; 2020 Dec; 72(6):650-662. PubMed ID: 33263367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
    Kulkarni GS; Hermanns T; Wei Y; Bhindi B; Satkunasivam R; Athanasopoulos P; Bostrom PJ; Kuk C; Li K; Templeton AJ; Sridhar SS; van der Kwast TH; Chung P; Bristow RG; Milosevic M; Warde P; Fleshner NE; Jewett MAS; Bashir S; Zlotta AR
    J Clin Oncol; 2017 Jul; 35(20):2299-2305. PubMed ID: 28410011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bladder Preservation Therapy: Review of Literature and Future Directions of Trimodal Therapy.
    El-Achkar A; Souhami L; Kassouf W
    Curr Urol Rep; 2018 Nov; 19(12):108. PubMed ID: 30392150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
    Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
    JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.
    Ploussard G; Daneshmand S; Efstathiou JA; Herr HW; James ND; Rödel CM; Shariat SF; Shipley WU; Sternberg CN; Thalmann GN; Kassouf W
    Eur Urol; 2014 Jul; 66(1):120-37. PubMed ID: 24613684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is trimodal therapy the current standard for muscle-invasive bladder cancer?
    López Valcárcel M; Barrado Los Arcos M; Ferri Molina M; Cienfuegos Belmonte I; Duque Santana V; Gajate Borau P; Fernández Ibiza J; Álvarez Maestro M; Sargos P; López Campos F; Couñago F
    Actas Urol Esp (Engl Ed); 2024 Jun; 48(5):345-355. PubMed ID: 38575067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.
    Johnson SB; Yu JB
    Curr Oncol Rep; 2018 Jun; 20(9):66. PubMed ID: 29959582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can bladder preservation therapy come to the center stage?
    Inamoto T; Ibuki N; Komura K; Juri H; Yamamoto K; Yamamoto K; Fujita K; Nonomura N; Narumi Y; Azuma H
    Int J Urol; 2018 Feb; 25(2):134-140. PubMed ID: 29171098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bladder sparing surgery in high-grade bladder cancer.
    Yakovlev PG; Klyushin DA; Vereshchako RI
    Exp Oncol; 2019 Jun; 41(2):160-165. PubMed ID: 31262149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy.
    Smith ZL; Christodouleas JP; Keefe SM; Malkowicz SB; Guzzo TJ
    BJU Int; 2013 Jul; 112(1):13-25. PubMed ID: 23356411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions.
    Jiang DM; Chung P; Kulkarni GS; Sridhar SS
    Curr Oncol Rep; 2020 Feb; 22(2):14. PubMed ID: 32008105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
    Giacalone NJ; Shipley WU; Clayman RH; Niemierko A; Drumm M; Heney NM; Michaelson MD; Lee RJ; Saylor PJ; Wszolek MF; Feldman AS; Dahl DM; Zietman AL; Efstathiou JA
    Eur Urol; 2017 Jun; 71(6):952-960. PubMed ID: 28081860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Landscape and Future Directions on Bladder Sparing Approaches to Muscle-Invasive Bladder Cancer.
    Broughman JR; Vuong W; Mian OY
    Curr Treat Options Oncol; 2020 Nov; 22(1):3. PubMed ID: 33230599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol.
    Tanabe K; Yoshida S; Koga F; Inoue M; Kobayashi S; Ishioka J; Tamura T; Sugawara E; Saito K; Akashi T; Fujii Y; Kihara K
    Clin Genitourin Cancer; 2015 Aug; 13(4):e243-e251. PubMed ID: 25936588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bladder-sparing trimodal therapy for muscle invasive bladder cancer].
    Khalifa J; Roumiguié M; Pouessel D; Sargos P
    Cancer Radiother; 2022 Oct; 26(6-7):771-778. PubMed ID: 35970682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer.
    Williams SB; Shan Y; Ray-Zack MD; Hudgins HK; Jazzar U; Tyler DS; Freedland SJ; Swanson TA; Baillargeon JG; Hu JC; Kaul S; Kamat AM; Gore JL; Mehta HB
    JAMA Surg; 2019 Aug; 154(8):e191629. PubMed ID: 31166593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Organ-sparing treatment of bladder cancer].
    Niedworok C; Shaleva A; Rübben H; Stenzl A
    Urologe A; 2016 May; 55(5):609-14. PubMed ID: 27119956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective multimodal bladder-sparing therapy for muscle-invasive bladder cancer: the present and the future.
    Koga F
    Expert Rev Anticancer Ther; 2023; 23(11):1127-1139. PubMed ID: 37753554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.